Redhill Biopharma Ltd ADR buy krebskrebs
Start price
03.01.22
/
50%
€2.51
Target price
03.01.23
€6.00
Performance (%)
-93.19%
End price
04.01.23
€0.17
Summary
This prediction ended on 04.01.23 with a price of €0.17. Massive losses of -93.19% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Redhill Biopharma Ltd ADR | - | - | - |
iShares Core DAX® | 3.054% | -1.396% | 15.789% |
iShares Nasdaq 100 | 4.389% | -5.391% | 29.906% |
iShares Nikkei 225® | 5.386% | -3.105% | 16.065% |
iShares S&P 500 | 2.955% | -3.011% | 25.903% |
Comments by krebskrebs for this prediction
In the thread Redhill Biopharma Ltd ADR diskutieren
Buy mit Kursziel 6,0
In the thread Trading Redhill Biopharma Ltd ADR
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten